Mary Bird Perkins Cancer Center is launching a $10 million adaptive radiation therapy program that uses a technology designed in Sweden to enhance the precision of radiation doses, the organization ...

Rochester Regional Health has installed a new adaptive radiation therapy system at Rochester General Hospital, expanding its cancer treatment capabilities. The health system announced Wednesday that ...

For patients with recurrent retroperitoneal sarcomas that cannot be treated surgically, treatment choices are limited. These tumors can grow quite large in the abdomen adjacent to vital organs or ...

BOROUGH PARK — MAIMONIDES CANCER CENTER HAS LAUNCHED A POWERFUL new technology and approach to standard radiation oncology therapy with a state-of-the-art Adaptive Radiation Therapy (ART) system that ...

MADISON, Wis., Oct. 2, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company has a 510(k) pending for an online adaptive therapy option*, Cenos™, for its Radixact® ...

The Ethos Clinical Observation Program offers radiation oncology professionals a unique opportunity to gain firsthand experience in the implementation and execution of online adaptive radiation ...

Bladder cancer radiotherapy has evolved significantly over recent years, with adaptive treatment techniques offering a promising approach to overcome the inherent challenges associated with treating a ...

In January, Cleveland-based University Hospitals Seidman Cancer Center became one of the first facilities in the U.S. to offer adaptive radiotherapy. At the time, Daniel Spratt, MD, chair of radiation ...

New Solution Provides an Unprecedented Set of Tools, Empowering Clinical Teams With Choice and Flexibility to Deliver Adaptive Care—Tailoring Radiotherapy to Each Patient's Unique Needs MADISON, Wis., ...

A study co-led by researchers at Miami Cancer Institute, part of Baptist Health South Florida, found that ablative stereotactic magnetic resonance (MR)-guided adaptive radiation therapy may improve ...

Use of serial ctDNA dynamics to predict clinical outcomes in metastatic and locally advanced PDAC: A systematic review. OS from diagnosis and RT versus PS+TS. Variable OS from diagnosis (months) OS ...